Renal safety evaluation of aspirin plus edaravone in patients with ischaemic stroke: a retrospective cohort study.

Hui-Qin YangWen-Jun YinKun LiuMan-Cang LiuXiao-Cong Zuo

Published in: BMJ open (2022)

Our study indicated that edaravone in patients with ischaemic stroke didn't increase the nephrotoxicity of aspirin, and even had a protective effect on mild renal deterioration. Nevertheless, there is a need to be cautious when patients are in bad pathophysiological conditions and at high risk of bleeding.

Keyphrases

low dose
end stage renal disease
ejection fraction
newly diagnosed
cardiovascular events
antiplatelet therapy
prognostic factors
peritoneal dialysis
atrial fibrillation
type diabetes